ArticleJournal of health economics and outcomes research2026
Natural History of Rare Tumor Risk Syndromes: A Scoping Review to Inform Cost-Effectiveness Models.
Carolina Di Fabrizio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.